-+ 0.00%
-+ 0.00%
-+ 0.00%

BNP Paribas Downgrades Organon to Neutral, Raises Price Target to $14

Benzinga·04/29/2026 17:51:40
Listen to the news
BNP Paribas analyst Navann Ty downgrades Organon (NYSE:OGN) from Outperform to Neutral and raises the price target from $12 to $14.